Anti-TWEAK monoclonal antibodies reduce vascular damage and leucocyte infiltration in a mouse model of cutaneous reverse passive Arthus reaction

2016 ◽  
Vol 41 (8) ◽  
pp. 871-877 ◽  
Author(s):  
T. Chen ◽  
Z.-P. Guo ◽  
L.-X. Fu ◽  
N. Cao ◽  
S. Qin
2013 ◽  
Vol 22 (7) ◽  
pp. 453-457 ◽  
Author(s):  
Tao Chen ◽  
Zai-pei Guo ◽  
Lin Wang ◽  
Sha Qin ◽  
Na Cao ◽  
...  

2021 ◽  
Author(s):  
Fatima Amanat ◽  
Shirin Strohmeier ◽  
Wen-Hsin Lee ◽  
Sandhya Bangaru ◽  
Andrew B Ward ◽  
...  

After first emerging in December 2019 in China, severe acute respiratory syndrome 2 (SARS-CoV-2) has since caused a pandemic leading to millions of infections and deaths worldwide. Vaccines have been developed and authorized but supply of these vaccines is currently limited. With new variants of the virus now emerging and spreading globally, it is essential to develop therapeutics that are broadly protective and bind conserved epitopes in the receptor binding domain (RBD) or the whole spike of SARS-CoV-2. In this study, we have generated mouse monoclonal antibodies (mAbs) against different epitopes on the RBD and assessed binding and neutralization against authentic SARS-CoV-2. We have demonstrated that antibodies with neutralizing activity, but not non-neutralizing antibodies, lower viral titers in the lungs when administered in a prophylactic setting in vivo in a mouse challenge model. In addition, most of the mAbs cross-neutralize the B.1.351 as well as the B.1.1.7 variants in vitro.


1998 ◽  
Vol 66 (3) ◽  
pp. 1057-1062 ◽  
Author(s):  
Rui Rong Yuan ◽  
Gadi Spira ◽  
Jin Oh ◽  
Melia Paizi ◽  
Arturo Casadevall ◽  
...  

ABSTRACT The isotype and epitope specificities of antibodies both contribute to the efficacy of antibodies that mediate immunity toCryptococcus neoformans, but the relationship between these properties is only partially understood. In this study, we analyzed the efficacy of protection of two sets of immunoglobulin G (IgG) isotype switch variants from two IgG3 monoclonal antibodies (MAbs) which are either not protective or disease enhancing, depending on the mouse model used. The two IgG3 MAbs 3E5 and 4H3 have different epitope specificities. Protection experiments were done with A/JCr mice infected intravenously with C. neoformans and administered with 3E5 IgG3 and its IgG1, IgG2a, and IgG2b switch variants. These experiments revealed that IgG1, IgG2b, and IgG2a were each more effective than IgG3. For 4H3 IgG3 and its IgG1 and IgG2b switch variants, the relative efficacy was IgG2b > IgG1 >> IgG3. The combination of 3E5 IgG3 and 4H3 IgG3 was more deleterious than either IgG3 alone. All IgG isotypes were opsonic for mouse bronchoalveolar cells, with the relative efficacy being IgG2b > IgG2a > IgG1 > IgG3. These results (i) confirm that a nonprotective IgG3 MAb can be converted to a protective MAb by isotype switching, (ii) indicate that the efficacy of protection of an IgG1 MAb can be increased by isotype switching to another subclass, (iii) show that protective and nonprotective IgG MAbs are opsonic, and (iv) provide additional evidence for the concept that the efficacy of the antibody response to C. neoformans is dependent on the type of MAb elicited.


2006 ◽  
Vol 175 (4S) ◽  
pp. 121-122
Author(s):  
Nathan Lawrentschuk ◽  
Angela Rigopoulos ◽  
Angela Mountain ◽  
Gareth Jones ◽  
Fook-Thean Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document